Injury to mtDNA in Peripheral Blood Mononuclear Cells Caused by Adefovir and Entecarvir treatment

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-TNRC-11001415

Enrollment

Unknown

Registered

2011-07-05

Start date

2007-07-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hepatitis B

Interventions

1:adefovir

2:entecavir

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Meet standard of National Program for Prevention and Treatment of Viral Hepatitis (2000)

Exclusion criteria

Exclusion criteria: 1. HAV/HCV/HDV/HEV and other virals infection; 2. alcohol or drug abuse and other liver injuries.

Design outcomes

Primary

Measure	Time frame
mitochondria DNA content of PBM;	—

Countries

China

Contacts

Public ContactLi Zhou

lxyu6@126.com+86 13366209490

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026